CD200 Gene

CD200 — Cluster of Differentiation 200

Introduction

CD200 (Cluster of Differentiation 200) is a widely expressed membrane glycoprotein that serves as a critical immune checkpoint molecule in the central nervous system. Originally identified as an immunoregulatory protein, CD200 interacts with its receptor CD200R to deliver inhibitory signals that suppress myeloid cell activation, including microglial cells in the brain. This signaling axis represents one of the most important mechanisms maintaining neuroimmune homeostasis["@wright2000"][@cardona2020].

CD200 — Cluster of Differentiation 200

Introduction

CD200 (Cluster of Differentiation 200) is a widely expressed membrane glycoprotein that serves as a critical immune checkpoint molecule in the central nervous system. Originally identified as an immunoregulatory protein, CD200 interacts with its receptor CD200R to deliver inhibitory signals that suppress myeloid cell activation, including microglial cells in the brain. This signaling axis represents one of the most important mechanisms maintaining neuroimmune homeostasis["@wright2000"][@cardona2020].

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">CD200 - Immune Checkpoint Glycoprotein</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>CD200</td></tr>
<tr><td><strong>Full Name</strong></td><td>CD200 Molecule (OX-2 Membrane Glycoprotein)</td></tr>
<tr><td><strong>Chromosome</strong></td><td>3q12-q13</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[1745](https://www.ncbi.nlm.nih.gov/gene/1745)</td></tr>
<tr><td><strong>OMIM</strong></td><td>155730</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000100288</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P14210](https://www.uniprot.org/uniprot/P14210)</td></tr>
<tr><td><strong>Protein Class</strong></td><td>Immunoglobulin Superfamily / Immune Checkpoint</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Multiple Sclerosis, Stroke, Brain Aging</td></tr>
</table>
</div>

Gene Structure and Protein Architecture

Gene Organization

The CD200 gene spans approximately 6.5 kb on chromosome 3q12-13 and consists of 5 exons encoding a 269 amino acid type I membrane glycoprotein. The gene structure is conserved across mammals, reflecting the fundamental importance of this immune regulatory pathway.

Protein Structure

The CD200 protein contains several distinct structural features[@baxter2011]:

| Feature | Details | Function |
|---------|---------|----------|
| N-terminal Ig-like domain | 1-120 | Ligand binding, receptor interaction |
| MHC-like domain | 120-200 | Structural stability |
| Proline-rich region | 200-230 | Flexibility |
| Transmembrane domain | 230-250 | Membrane anchoring |
| Cytoplasmic tail | 250-269 | Signaling (minimal) |

As a type I membrane protein, CD200 presents its extracellular Ig-like domain for interaction with CD200R on neighboring cells. The cytoplasmic tail is remarkably short, suggesting that CD200 functions primarily as a ligand rather than a signaling molecule itself.

Expression Pattern

CD200 is broadly expressed in the central nervous system:

| Cell Type | Expression Level | Notes |
|-----------|------------------|-------|
| Neurons | High | Particularly in cortex, hippocampus |
| Astrocytes | Moderate | Variable by region and state |
| Oligodendrocytes | Moderate | Higher in mature cells |
| Endothelial cells | High | Blood-brain barrier expression |
| Microglia | Low | Minimal expression under normal conditions |

The CD200-CD200R Signaling Axis

Receptor Distribution

CD200R (CD200 Receptor) is expressed predominantly on myeloid cells:

• Microglia: High expression in resting/ surveilling state
• Macrophages: Peripheral immune cells
• Dendritic cells: Antigen-presenting cells
• Some T cells: Subset of adaptive immune cells

Signaling Mechanism

Upon CD200-CD200R interaction, the following sequence occurs[@hoek2000][@baxter2011]:

This mechanism provides a constitutive "off signal" that keeps microglia in a quiescent state under normal conditions.

Comparison to Other Immune Checkpoints

The CD200-CD200R axis shares conceptual similarities with other immune checkpoint pathways:

| Checkpoint | Ligand | Receptor | Primary Function |
|------------|--------|----------|------------------|
| CD200-CD200R | CD200 | CD200R | Inhibits myeloid cell activation |
| PD-1/PD-L1 | PD-L1 | PD-1 | T cell exhaustion |
| CTLA-4/CD80 | CD80 | CTLA-4 | T cell co-stimulation blockade |

However, CD200-CD200R is unique in its constitutive expression and role in CNS immune homeostasis.

Role in Neuroinflammation

Normal CNS Immune Homeostasis

Under physiological conditions, CD200-CD200R signaling maintains microglia in a resting state characterized by[@zhang2011][@cardona2020]:

• Small soma size with extended processes
• Low expression of activation markers (CD68, MHC-II)
• Limited phagocytic activity
• Production of anti-inflammatory cytokines (IL-10, TGF-β)
• Surveillance of the neural environment

Inflammation and Dysregulation

In neurodegenerative diseases, the CD200-CD200R axis is disrupted through multiple mechanisms[@walker2019]:

Reduced CD200 Expression:

• Neuronal CD200 levels decrease with aging
• Neuropathology (Aβ, tau) further reduces expression
• Epigenetic silencing may occur

• Microglial CD200R may be downregulated
• Signaling efficacy may be impaired
• Alternative splicing may produce non-functional isoforms

• Loss of inhibitory signaling
• Microglial hyperactivation
• Chronic neuroinflammation
• Synaptic dysfunction and loss

Disease Associations

Alzheimer's Disease

CD200 dysfunction contributes to AD pathogenesis through multiple mechanisms[@stuart2021][@wang2020]:

Amyloid Effects:

• Aβ accumulation reduces neuronal CD200 expression
• Loss of CD200 signaling exacerbotes microglial activation around plaques
• Creates a feed-forward loop of inflammation and pathology

• CD200 deficiency contributes to synaptic loss
• Microglial phagocytosis of synapses increases
• Cognitive decline correlates with CD200 dysregulation

• CD200 agonists are being developed
• AAV-mediated CD200 overexpression in preclinical models
• Small molecules to enhance CD200-CD200R signaling

Parkinson's Disease

In PD, the CD200-CD200R pathway is implicated in dopaminergic neuron survival[@liu2019]:

Substantia Nigra Vulnerability:

• Dopaminergic neurons express high CD200
• Loss of CD200 in PD brain contributes to microglia activation
• Inflammation specifically targets vulnerable regions

• CD200 overexpression protects neurons in models
• CD200R activation reduces oxidative stress
• Potential for disease modification

Multiple Sclerosis

CD200 signaling is altered in MS and related demyelinating diseases[@mengel2017]:

Lesion Environment:

• CD200 expression is reduced in demyelinating lesions
• MS lesions show increased microglial activation
• Loss of immune regulation contributes to autoimmunity

• CD200-based therapies may promote remyelination
• Modulating this pathway could reduce relapse severity

Stroke and Brain Injury

Following ischemic injury, CD200 plays complex roles[@ton2019]:

Acute Phase:

• CD200 expression initially increases
• May limit initial inflammatory damage

• CD200 levels often decline
• Contributes to prolonged inflammation
• Impairs functional recovery

• Timing of CD200 modulation is critical
• Acute vs. chronic interventions differ

Aging and Cognitive Decline

CD200 expression naturally declines with aging[@gomes2018]:

• 30-40% reduction in aged brain
• Contributes to age-related neuroinflammation
• May explain increased susceptibility to neurodegeneration

Interaction Network

CD200 interacts with multiple proteins and pathways:

| Partner | Interaction Type | Functional Significance |
|---------|------------------|------------------------|
| CD200R | Direct binding | Primary signaling receptor |
| CD200R1 | Alternative receptor | Similar inhibitory function |
| SHP-1 | Downstream signaling | Phosphatase recruitment |
| SHP-2 | Downstream signaling | Phosphatase recruitment |
| Aβ oligomers | Pathological interaction | Reduces CD200 expression |
| NFTs | Pathological association | Tau pathology impact |

Therapeutic Implications

Targeting the CD200-CD200R Axis

Multiple therapeutic strategies are being explored[@walker2019]:

Agonist Development:

• CD200-Fc fusion proteins (recombinant)
• Anti-CD200R activating antibodies
• Small molecule agonists

• AAV-mediated CD200 overexpression
• CRISPR approaches to enhance expression
• Cell-type specific delivery

• CD200 modulation with immunomodulators
• Synergistic with Aβ/tau targeting
• Adjunctive to existing therapies

Challenges and Considerations

• Blood-brain barrier: Delivery to CNS is challenging
• Timing: Acute vs. chronic interventions differ
• Specificity: Avoiding off-target immune suppression
• Balance: Some inflammation is beneficial for repair

Key Publications

See Also

• [CD200 Protein](/proteins/CD200-Protein) - Protein page
• [CD200R1 Gene](/genes/CD200R1) - Receptor gene
• [CD200R1 Protein](/proteins/CD200R1-Protein) - Receptor protein page
• [Microglia](/cell-types/microglia-neuroinflammation) - Cell type page
• [Neuroinflammation Pathway](/mechanisms/neuroinflammation-pathway) - Mechanism page
• [Alzheimer's Disease](/diseases/alzheimers-disease) - Disease page
• [Parkinson's Disease](/diseases/parkinsons-disease) - Disease page

External Links

• [GeneCards - CD200](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD200)
• [UniProt - CD200](https://www.uniprot.org/uniprot/P14210)
• [NCBI Gene - CD200](https://www.ncbi.nlm.nih.gov/gene/1745)
• [OMIM - CD200](https://www.omim.org/entry/155730)
• [Ensembl - CD200](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000100288)
• [Allen Brain Atlas - CD200](https://human.brain-map.org/microarray/search/show?search_term=CD200)

Pathway Diagram

The following diagram shows the key molecular relationships involving CD200 Gene discovered through SciDEX knowledge graph analysis: